Long non-coding RNA TMPO-AS1 promotes tumor progression via sponging miR-140-5p in breast cancer

Long non-coding RNAs (lncRNAs) are involved in carcinogenesis and tumor suppression, and are novel biological tumor regulators. However, the functional roles of lncRNAs and their underlying dysregulation mechanisms in breast cancer are not completely understood. The aim of the present study was to investigate the clinical significance and biological functions of lncRNA TMPO antisense RNA 1 (TMPO-AS1) in breast cancer. TMPO-AS1 levels were measured in human cancer tissues and breast cancer cell lines, and the functional roles of TMPO-AS1 in breast cancer cells were investigated by performing in vitro and in vivo assays. Additionally, luciferase reporter assays were conducted to detect the association between microRNA (miR)-140-5p and TMPO-AS1. TMPO-AS1 expression levels were significantly increased in breast cancer tissues and cell lines compared with adjacent non-cancerous tissues and MCF-10A cells, respectively. In vitro and in vivo studies indicated that TMPO-AS1 knockdown significantly suppressed breast cancer cell viability at 48 and 72 h compared with the small interfering (si)RNA negative control group (NC; siNC). TMPO-AS1 knockdown in vitro inhibited MCF-7 and T47D cell migration and invasion compared with the siNC group. TMPO-AS1 knockdown in metastatic breast cancer cells also decreased metastatic colonization in the mouse lung compared with the short hairpin RNA NC group. Mechanistically, TMPO-AS1 promoted cellular viability and migration as a competing endogenous RNA by sponging miR-140-5p. The results suggested that TMPO-AS1 may serve as a potential therapeutic target in patients with breast cancer.

[1]  K. Horie-Inoue,et al.  Proliferation‐associated long noncoding RNA, TMPO‐AS1, is a potential therapeutic target for triple‐negative breast cancer , 2020, Cancer science.

[2]  Xin Zhang,et al.  LINC00346 promotes hepatocellular carcinoma progression via activating the JAK‐STAT3 signaling pathway , 2020, Journal of cellular biochemistry.

[3]  Xinyu Zheng,et al.  Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing miR-708-5p Expression and Activity , 2019, Molecular therapy. Nucleic acids.

[4]  Liang He,et al.  Long Non-coding RNA LINC00114 Facilitates Colorectal Cancer Development Through EZH2/DNMT1-Induced miR-133b Suppression , 2019, Front. Oncol..

[5]  Z. Shao,et al.  LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription , 2019, Molecular Cancer.

[6]  Hongyan Qu,et al.  lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR‐219‐1 , 2019, Journal of cellular biochemistry.

[7]  Qian Yang,et al.  Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER/NF-κB pathway in non-small-cell lung cancer. , 2019, American journal of translational research.

[8]  Yuanting Gu,et al.  lncRNA GHET1 knockdown suppresses breast cancer activity in vitro and in vivo. , 2019, American journal of translational research.

[9]  K. Horie-Inoue,et al.  Prostate cancer-associated lncRNAs. , 2018, Cancer letters.

[10]  Yan Wang,et al.  Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion. , 2017, Biochemical and biophysical research communications.

[11]  Xuegong Zhang,et al.  Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq. , 2017, Lung cancer.

[12]  W. Muller,et al.  LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis , 2017, Nature Communications.

[13]  G. Lianos,et al.  Breast cancer in young women: an overview , 2017, Updates in Surgery.

[14]  R. O'Regan,et al.  AR Signaling in Breast Cancer , 2017, Cancers.

[15]  M. Schweizer,et al.  AR-Signaling in Human Malignancies: Prostate Cancer and Beyond , 2017, Cancers.

[16]  Peiheng He,et al.  miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675. , 2016, American journal of translational research.

[17]  Leng Han,et al.  The LINK-A lncRNA Activates Normoxic HIF1α Signaling in Triple-negative Breast Cancer , 2016, Nature Cell Biology.

[18]  A. Jemal,et al.  Breast cancer statistics, 2015: Convergence of incidence rates between black and white women , 2016, CA: a cancer journal for clinicians.

[19]  Ahmedin Jemal,et al.  Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[20]  Pei Han,et al.  Long non-coding RNA and chromatin remodeling , 2015, RNA biology.

[21]  L. Sempere,et al.  Critical analysis of the potential for microRNA biomarkers in breast cancer management , 2015, Breast cancer.

[22]  Akhil Varshney,et al.  Non‐coding RNAs: biological functions and applications , 2015, Cell biochemistry and function.

[23]  Jean Hausser,et al.  MicroRNA binding sites in the coding region of mRNAs: Extending the repertoire of post‐transcriptional gene regulation , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[24]  F. Liu,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[25]  M. Dowsett,et al.  Biomarkers for the clinical management of breast cancer: International perspective , 2013, International journal of cancer.

[26]  Nancy M Bonini,et al.  MicroRNAs and neurodegeneration: role and impact. , 2013, Trends in cell biology.

[27]  Andrea Masotti,et al.  Recent Insights and Novel Bioinformatics Tools to Understand the Role of MicroRNAs Binding to 5′ Untranslated Region , 2012, International journal of molecular sciences.

[28]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[29]  P. Pandolfi,et al.  In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma , 2011, Cell.

[30]  P. Pandolfi,et al.  In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma , 2011, Cell.

[31]  Xuerui Yang,et al.  An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma , 2011, Cell.

[32]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[33]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.

[34]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[35]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[36]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[37]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[38]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[39]  Yusuf A. Hannun,et al.  Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.

[40]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[41]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[42]  S. Parlee,et al.  This Work Is Licensed under a Creative Commons Attribution-noncommercial 4.0 International License , 2022 .